… can be further modified. These modifications include use of pathogen inactivation technology (see Chapter 19, Pathogen-reduced platelets in this Guide ), suspension in platelet …

… . To improve blood safety, many countries have implemented pathogen inactivation technologies to reduce the risk of … 2021, Health Canada approved the use of Cerus INTERCEPT Pathogen Inactivation Technology (PIT) for manufacturing … stem cell transplant patients who received pathogen-reduced platelets that were both not irradiated nor …

… related to increases in the risk of infectious diseases, reduced vitality, vasovagal reactions and low iron levels . … by someone trained to provide support and be reassuring reduced vasovagal reactions in donors with a history of < 3 … as a precautionary step to prevent the introduction of a pathogen into the blood supply.  Canadian Blood Services …

… on Canadian Blood Services platelet bacterial screening . Pathogen inactivation adds an extra layer of protection against a number of pathogens, including bacteria and viruses. By effectively … transmission. See Chapter 19 for more about pathogen-reduced platelets.   Dyspnea Dyspnea or hypoxemia can occur …

… . Lu W, Fung M. Platelets Treated with Pathogen Reduction Technology: Current Status and Future … . Devine DV, Schubert P. Pathogen Inactivation Technologies: The Advent of Pathogen-Reduced Blood Components to Reduce Blood Safety Risk. …